Victory Capital Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7M | Buy |
450,619
+229,800
| +104% | +$7.47M | 0.01% | 987 |
|
|
2025
Q1 | $8.34M | Sell |
220,819
-82,737
| -27% | -$3.12M | 0.01% | 1118 |
|
|
2024
Q4 | $24.8M | Buy |
303,556
+48,516
| +19% | +$3.97M | 0.02% | 761 |
|
|
2024
Q3 | $29.1M | Sell |
255,040
-52,476
| -17% | -$6M | 0.03% | 685 |
|
|
2024
Q2 | $23.2M | Buy |
307,516
+26,641
| +9% | +$2.01M | 0.02% | 751 |
|
|
2024
Q1 | $19.2M | Sell |
280,875
-98,532
| -26% | -$6.73M | 0.02% | 834 |
|
|
2023
Q4 | $23.8M | Sell |
379,407
-51,542
| -12% | -$3.24M | 0.03% | 712 |
|
|
2023
Q3 | $22M | Sell |
430,949
-31,355
| -7% | -$1.6M | 0.03% | 715 |
|
|
2023
Q2 | $23.1M | Buy |
462,304
+69,055
| +18% | +$3.45M | 0.03% | 720 |
|
|
2023
Q1 | $14.7M | Buy |
393,249
+325,536
| +481% | +$12.2M | 0.02% | 891 |
|
|
2022
Q4 | $3.25M | Buy |
67,713
+11,693
| +21% | +$561K | ﹤0.01% | 1309 |
|
|
2022
Q3 | $1.34M | Sell |
56,020
-17,610
| -24% | -$422K | ﹤0.01% | 1603 |
|
|
2022
Q2 | $1.6M | Sell |
73,630
-15,380
| -17% | -$335K | ﹤0.01% | 1541 |
|
|
2022
Q1 | $2.15M | Buy |
+89,010
| New | +$2.15M | ﹤0.01% | 1473 |
|
|
2020
Q4 | – | Sell |
-5,102
| Closed | -$252K | – | 2574 |
|
|
2020
Q3 | $252K | Buy |
+5,102
| New | +$252K | ﹤0.01% | 2222 |
|